Comments
Drug firm Ajanta Pharma on Tuesday reported a 64 per cent rise in its consolidated net profit to ₹177 crore for the quarter ended December mainly on account of robust sales.
The company had posted a net profit of ₹108 crore for the corresponding period of the previous fiscal, Ajanta Pharma said in a BSE filing.
Consolidated revenue from operations of the company stood at ₹749 crore for the quarter under consideration. It was ₹651 crore for the same period a year ago, it added.
Shares of Ajanta Pharma closed at ₹1,746.15 apiece on the BSE, down 0.59 percent from its previous close.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.